Nichi-Iko Pharmaceutical
engages in manufacturing and commercializing prescription drugs issued by hospitals, clinics, pharmacies and drug stores... Read moreNichi-Iko Pharmaceutical
engages in manufacturing and commercializing prescription drugs issued by hospitals, clinics, pharmacies and drug stores... Read more
News
Apr 10, 2023
Global Legal Chronicle
Nichi-Iko Pharmaceutical: Elliminist Singapore's $100 Million Acquisition of Nichi-Iko Pharmaceutical Co.
Mar 08, 2023
MarketScreener
Nichi-Iko Pharmaceutical: Mar. 08, 2023TSE Decision on Delisting, etc.: Nichi-Iko Pharmaceutical Co.,Ltd.
Nov 15, 2022
MarketScreener
Nichi-Iko Pharmaceutical: Nov. 15, 2022TSE Designation of Securities Under Supervision (Confirmation): Nichi-Iko Pharmaceutical Co.,Ltd.
May 18, 2022
Asian Venture Capital Journal
Nichi-Iko Pharmaceutical: Japan Industrial Solutions supports troubled local drug maker
May 13, 2022
FirstWord Pharma
Nichi-Iko Pharmaceutical: Nichi-Iko Pharma seeks debt restructuring aided by white knight
Dec 03, 2021
MarketScreener
Nichi-Iko Pharmaceutical: Nichi Iko Pharmaceutical : DelayedConsolidated Financial Results for the Second Quarter of the Fiscal Year Ending March 31, 2022 (IFRS)
Sep 06, 2021
MarketScreener
Nichi-Iko Pharmaceutical: Nichi Iko Pharmaceutical : DelayedConsolidated Financial Results for the First Quarter of the Fiscal Year Ending March 31, 2022 (IFRS)
Jun 17, 2020
MarketScreener
Nichi-Iko Pharmaceutical: Japan's Nichi-Iko jumps on hopes for steroid sales boost to treat COVID-19
Jun 10, 2020
Biospectrum Asia
Nichi-Iko Pharmaceutical: Japan explores Nafamostat inhalation formulation for COVID-19 treatment, Read more
Jun 09, 2020
Pharmabiz
Nichi-Iko Pharmaceutical: The University of Tokyo, RIKEN, NichiIko & Daiichi Sankyo ink collaborative R&D on nafamostat inhalation formulation to treat COVID19
